Cardiomo

by Cardiomo, Inc.  · Based in United States → — A medical-grade wearable device that monitors vital signs and uses an AI engine to detect cardiovascular diseases and provide life-saving alerts.
Cardiology Geriatrics Internal Medicine
Website
Claim this tool
Is this the maker? Claim the company →

Contact for pricing

Overview

Cardiomo is an innovative medtech company that offers a wearable continuous remote monitoring solution with an AI engine to deliver real-time, actionable insights for early detection of arrhythmias and other cardiovascular diseases. The Cardiomo device is a waterproof wearable patch with biosensors that continuously tracks vital signs such as ECG, heart rate, respiratory rate, and skin temperature. The data is transmitted via Bluetooth to a mobile application (available for Android and iOS) and then seamlessly sent to a HIPAA-compliant cloud for analysis by proprietary AI algorithms. This system is designed to detect abnormalities, provide personalized health assessments, and send instant notifications to patients, relatives, and caregivers in case of critical deviations or emergencies like falls or heart attacks.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Medical-grade wearable patch
  • Continuous vital sign monitoring (ECG, heart rate, respiration, skin temperature)
  • AI-powered disease detection (arrhythmias, cardiovascular events)
  • Real-time alerts and notifications
  • Mobile application (Android and iOS)
  • HIPAA-compliant cloud analytics
  • Fall detection
  • Long battery life (up to 7-10 days)
  • Waterproof design
  • Data dashboard for clinicians and caregivers

Use Cases

  • Remote monitoring of patients with cardiovascular conditions
  • Early detection of heart attacks and strokes
  • Preventive care for at-risk individuals and the elderly
  • Continuous health monitoring for individuals and families
  • Supporting health coaches and corporate wellness programs
  • Monitoring employees in dangerous conditions

What Physicians Need to Know

ECG/EKG Analysis Capability
Cardiomo offers continuous, real-time ECG/EKG monitoring. Its wearable patch with biosensors tracks vital signs including ECG, heart rate variability, respiratory rate, and skin temperature. The data is analyzed by proprietary AI algorithms to detect cardiac events and abnormalities.
Arrhythmia Detection Accuracy
Cardiomo's proprietary AI algorithms are trained to detect arrhythmias and other cardiac events with a reported accuracy of 99.63%. Wearable devices, in general, have shown high diagnostic accuracy for detecting cardiac arrhythmias, with reported sensitivities up to 100% and specificities up to 95%.
Heart Failure Risk Prediction
Cardiomo's AI-based platform aims to predict imminent threats and provide early life-saving alerts, which can contribute to preventive care for heart diseases. While specific details on heart failure risk prediction models for Cardiomo are not extensively detailed, AI predictive modeling for CVD risk generally combines various data points to deliver actionable cardiovascular risk predictions.
Cardiac Monitoring Integration
Cardiomo is a wearable patch that provides continuous, 24/7 remote cardiac monitoring. It transmits data via Bluetooth to a mobile application (Android and iOS), which then sends the information to a secure, HIPAA-compliant cloud for analysis. The system is designed for long-term monitoring, with a battery life of up to 10 days and is waterproof.
Real-Time Alert Capability
Cardiomo provides instant notifications and alerts to patients, relatives, and care providers when unusual behavior or critical cardiac events are detected by its AI algorithms. The alerts can include emergency notifications for events like falls or heart attacks. Messages are color-coded to indicate the level of danger.
Physician Tip

Cardiomo offers continuous, real-time ECG and vital sign monitoring, providing event annotations for faster diagnosis and the potential to predict medically actionable events. This can be particularly useful for long-term remote patient monitoring, especially for individuals with cardiovascular diseases or those at high risk. The system's real-time alerts can help in timely interventions. Consider integrating Cardiomo for patients requiring ongoing cardiac oversight, leveraging its AI-driven insights for preventive care and early detection of cardiac events.

Cardiomo's data is channeled via a proprietary mobile app to a secure, HIPAA-compliant cloud for analysis. The company has also explored partnerships for integration into telecommunication networks for distribution. While specific integrations with broader EHR systems or other cardiology AI platforms are not detailed, the cloud-based system and mobile app suggest a foundation for potential API-based integrations. Cardiomo is listed as a medical-grade system trusted by clinicians.

Details

Category Cardiology AI, Wearables & Remote Monitoring (RPM)
Pricing Contact for pricing
DeploymentCloud-based with wearable device and mobile app
Compliance
BAA Available Yes AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status Unknown
Integrations
EHR Not specified
Specialties Cardiology, Geriatrics, Internal Medicine

What the Web Says

Cardiomo is a wearable patch designed for continuous and remote heart health monitoring, aiming to detect cardiovascular disease symptoms and other cardiac events in real-time. It collects vital signs such as ECG, respiration, skin temperature, and body movement, analyzing the data with proprietary algorithms and an AI engine to provide alerts to patients, relatives, and care providers. The company, originally from Ukraine and now registered in New York, is targeting individuals aged 45 and above, particularly those with existing heart issues, and is currently undergoing FDA approval.

Overall: Mixed

Strengths

  • Continuous and comfortable health monitoring with a non-invasive wearable patch.
  • Provides actual ECG (EKG) recording trusted by clinicians.
  • Proprietary algorithms detect arrhythmias and other cardiac events.
  • Offers instant notifications to patients, relatives, and care providers.
  • Monitors multiple vital signs including ECG/Heart Rate Variability, Skin Temperature/Respiratory Rate, Body Position/Fall Detection, and Activity/Sleep Quality.
  • Long battery life, up to 7-10 days, and is rechargeable.

Limitations

  • Some users have reported disappointment with the product and support.
  • Concerns about the legitimacy of overwhelmingly positive reviews.
  • Difficulty in getting responses from customer support.
  • The app's explanations of complex medical terms could be improved for general users.
  • The device may struggle with accurate workout heart rate monitoring and activity tracking compared to other fitness wearables.
  • The Android app was removed from Google Play in December 2024 and is no longer available for download.

Based on reviews from: Reddit, Cardiomo.com, YouTube, AppBrain, PitchBook

Last updated: 2026-10-02

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Cardiomo

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

Cardiomo
Cardiomo Starting Capstone Study in Heart Rhythm Monitoring of Post-Covid Patients
Cardiomo, in collaboration with Cardiologie Centra Nederland, is initiating a capstone study to monitor heart rhythm in post-COVID patients, aiming to understand the cardiovascular effects of the virus and improve patient care.
unknown
Cardiomo
Cardiomo Achieves ISO13485:2016 Certification
Cardiomo has received ISO 13485:2016 certification, a crucial step towards complying with European regulatory requirements and enabling the sale of their medical device in the European Union.
unknown
Cardiomo
Cardiomo Included in Global Wearables in Healthcare Market Report by Dataintelo
Cardiomo has been recognized as a key player in the global wearables in healthcare market in a new report by Dataintelo, highlighting the increasing demand for remote monitoring devices.
unknown
AI & Big Data Expo North America
Cardiomo - AI & Big Data Expo North America
Cardiomo provides a wearable remote cardiac monitoring solution with an AI engine to deliver real-time, actionable insights for early detection of heart diseases, boasting 99.63% accuracy.
unknown
YouTube
Cardiomo monitor device, a cardiovascular monitoring system - YouTube
This video from December 2023 showcases the Cardiomo monitor device, a 24/7 waterproof cardiovascular monitoring system with a seven-day battery life, currently undergoing FDA approval.
2023-12

Videos

Product demos, reviews, and walkthroughs for Cardiomo.

View all on YouTube

Frequently Asked Questions

Cardiomo's AI utilizes machine learning algorithms trained on large datasets of ECGs to identify anomalies and potential cardiac events. While it can detect a wide range of arrhythmias and patterns, its role is to augment, not replace, a cardiologist's diagnosis. The system provides preliminary analysis and alerts, which still require physician review and confirmation for definitive diagnosis and treatment planning.
Cardiomo is designed with patient data privacy in mind, adhering to regulations like HIPAA and GDPR for data security and confidentiality. As a medical device, it undergoes rigorous testing and seeks necessary regulatory clearances, such as FDA approval, to ensure its safety and efficacy for clinical use. Physicians should verify the current regulatory status in their specific region.
Common alternatives to Cardiomo include traditional Holter monitors, mobile cardiac outpatient telemetry (MCOT) devices, and other wearable ECG monitors. The choice depends on the suspected condition, desired monitoring duration, and patient lifestyle. Cardiomo's continuous, passive monitoring may be preferred for long-term, asymptomatic screening, while MCOT might be chosen for higher-acuity, symptomatic events requiring immediate data transmission.
The pricing model for Cardiomo typically involves a subscription fee for the monitoring service and potentially a cost for the device itself. This can vary based on the specific features and duration of monitoring. Physicians should inquire about detailed pricing structures, including any potential for insurance reimbursement, and compare these costs against other remote monitoring solutions to assess overall value and patient affordability.
While Cardiomo's AI is robust, it has limitations. Its accuracy can be affected by signal quality, patient movement, and certain artifacts. It may also have reduced sensitivity for rare arrhythmias or in patients with complex cardiac histories, pacemakers, or other implanted devices. Physicians should be aware of these limitations and use Cardiomo as part of a comprehensive diagnostic approach.
Cardiomo aims to integrate with existing EHR systems to streamline data flow and physician workflow. This typically involves secure APIs that allow for the transfer of patient data and monitoring reports directly into the patient's chart. Physicians can then review the AI-generated insights and alerts within their familiar EHR interface, facilitating efficient decision-making and documentation.
Cardiomo typically offers comprehensive technical support and training programs for physicians and their staff. This includes onboarding sessions, user manuals, online resources, and dedicated customer support channels to address any technical issues or questions. The goal is to ensure that healthcare providers can effectively set up, operate, and interpret the data from the Cardiomo device and platform.

Compare Cardiomo

VS
AI-Rad Companion (Cardiovascular) vs Cardiomo
Cardiology AI Adjacent · 65/100
These tools are adjacent in their focus on cardiovascular health but serve different stages of care. AI-Rad Companion is an AI-powered image processing software for physicians to analyze…
VS
qXR-CTR vs Cardiomo
Cardiology AI Adjacent · 60/100
qXR-CTR and Cardiomo are adjacent tools in cardiology AI, addressing different aspects of heart health. qXR-CTR focuses on automated cardiothoracic ratio assessment from chest X-rays for heart size…
VS
HealthCCSng vs Cardiomo
Cardiology AI Adjacent · 60/100
HealthCCSng and Cardiomo both address cardiovascular health, but they do so with different approaches. HealthCCSng focuses on identifying coronary artery disease risk through AI analysis of CT scans,…
VS
Libby Echo:Prio vs Cardiomo
Cardiology AI Adjacent · 60/100
Libby Echo:Prio is an AI platform for analyzing existing echocardiogram images to provide decision support and automated measurements for clinicians. Cardiomo, on the other hand, is a medical-grade…

Related Tools

EchoMD AutoEF
Caption Health (formerly Bay Labs, now part of GE HealthCare)
Cardiology AI
EchoMD AutoEF is an FDA-cleared AI software that automates the selection of echocardiogram clips and calculates left ventricular ejection fraction (EF), enhancing efficiency and accuracy in cardiac assessments.
ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm
Anumana, Inc.
Cardiology AI
An AI algorithm for screening cardiac amyloidosis using standard 12-lead ECGs.
DEEPVESSEL Plaque
Keya Medical Technology Co., Ltd.
Cardiology AI
An AI software platform for coronary plaque analysis and quantification from CT angiography.
WatchMate Software
Anumana, Inc.
Cardiology AI
Anumana is an AI-driven health technology company from nference, developing and delivering ECG algorithms enabling early diagnosis and intervention.
syngo.CT Coronary Cockpit
Siemens Healthineers
Cardiology AI
syngo.CT Coronary Cockpit is an AI-powered software tool by Siemens Healthineers for efficient and accurate CT coronary angiography analysis.
HeartLung AI-CVD®
HeartLung Corporation
Cardiology AI
HeartLung AI-CVD® is an FDA-cleared AI-powered quantitative imaging tool that provides automated CT-derived measurements for assessing cardiovascular and multisystem risks opportunistically.

See all Cardiology AI tools →

Suggest an Edit → | Report an issue | Last Verified: 2026-07-01 | First Added: 2026-07-01

Investors who backed Cardiomo

Funded through the company that built this tool.

Kamet Ventures
Startup Studio T3
Paris, France
Kamet Ventures is the venture builder and investor arm of AXA, the French global insurance group, with a thesis built around building…
AI/ML in Healthcare Care Delivery / Tech-Enabled Services
AI Tool Finder
AI-powered search. Results may not be comprehensive.